Sexual Dysfunction and Quality of Life in Patients with Hidradenitis Suppurativa and Their Partners
Bibliographic Data
| ID | 15458656 |
|---|---|
| Authors | Carlos Cuenca‐Barrales (0000-0001-7579-4931, Instituto de Investigación Biosanitaria de Granada), Trinidad Montero‐Vílchez (0000-0003-4035-7955, Instituto de Investigación Biosanitaria de Granada), Piotr K Krajewski (0000-0003-4722-8531, Wroclaw Medical University), Jacek C Szepietowski (0000-0003-0766-6342, Wroclaw Medical University), Łukasz Matusiak (0000-0003-2067-4929, Wroclaw Medical University), Salvador Arias‐Santiago (0000-0002-4186-1435, Universidad de Granada, corresponding author), Alejandro Molina‐Leyva (0000-0001-6882-2113, Instituto de Investigación Biosanitaria de Granada) |
| Year | 2022 |
| Volume | 20 |
| Issue | 1 |
| Pages | 389-389 |
| Publication date | 2022-12-26 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Environmental Research and Public Health (JOURNAL) |
| Journal identifiers | ISSN: 1661-7827 • E-ISSN: 1660-4601 |
| Publisher | Multidisciplinary Digital Publishing Institute (PUBLISHER • CH) |
| DOI | 10.3390/ijerph20010389 |
| PMID | 36612709 |
| OpenAlex | W4313260546 |
| Language | EN |
| References cited | 45 |
Hidradenitis suppurativa (HS) is a chronic skin disease that profoundly affects patients' quality of life (QoL) and sexuality. Few data are available on the impact of HS on patients' partners. We aimed to explore the QoL and sexual function of patients' partners and the factors associated with their impairment and to compare the QoL and sexual function of single patients and those in a stable relationship. We conducted a cross-sectional study at Hospital Universitario Virgen de las Nieves (Granada, Spain) and at the Wroclaw Medical University (Wroclaw, Poland). Patients over the age of 16 years attending their scheduled follow-up and their partners, if any, were included. The Dermatology Life Quality Index (DLQI) and the Family Dermatology Life Quality Index (FDLQI) were used to estimate the QoL of patients and partners, respectively. The FSFI-6 was used to determine sexual dysfunction in women and the IIEF-5 for erectile dysfunction in men. Thirty-four single patients and twenty-eight patients in a stable relationship and their partners were included. Patients had a very large impact (DLQI 12.5 ± 7.5) and their partners a moderate impact (FDLQI 10.3 ± 7.1) in their QoL due to HS. Women with HS had a high prevalence of sexual dysfunction (13/32, 40.6%) and men of erectile dysfunction (19/30, 63.3%). Male partners also had a high prevalence of erectile dysfunction (10/17, 58.8%), while only one female partner had sexual dysfunction (1/11, 9.1%). Factors related to disease severity, intensity of symptoms and body mass index were associated with poorer QoL in partners and time of disease evolution with greater erectile dysfunction in male partners. In conclusion, HS not only profoundly affects the QoL and sexuality of patients but also of their partners. Several risk factors have been identified, which should be taken into account in the holistic approach of the disease
Cross-sectional study · Dermatology Life Quality Index · Disease · Erectile dysfunction · Erectile function · Hidradenitis suppurativa · Human sexuality · Pathology · Physical therapy · Quality of life (healthcare · Sexual dysfunction · Sexual function · Hidradenitis Suppurativa and Treatments · Medicine · Internal Medicine
| Highly cited | No |
|---|